Pfizer Rises 5.6% in a Month: How Should You Play the Stock?

Pfizer’s (PFE) stock has risen 5.6% in the past month. This was due to the company’s encouraging guidance for 2025 issued in mid-December 2025. Pfizer also maintained its previously issued financial guidance for 2024.Pfizer projected total revenues between $61.0 billion and $64.0 billion in 2025. On an operational basis, revenues in 2025 are expected to be approximately flat to up 5% from the midpoint of 2024 guidance, excluding the impact of approximately $1.2 billion of non-recurring revenues for Paxlovid ...